TreeWAS – Variant ID: rs7130881

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C61 Malignant neoplasm of prostate	1.000	0.000	0.000
C60-C63 Malignant neoplasms of male genital organs	0.294	0.706	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.211	0.789	0.000
C60 Malignant neoplasm of penis	0.211	0.789	0.000
C60.9 Penis, unspecified	0.151	0.848	0.000
C60.8 Overlapping lesion of penis	0.151	0.848	0.000
C60.2 Body of penis	0.151	0.848	0.000
C60.1 Glans penis	0.151	0.848	0.000
C60.0 Prepuce	0.151	0.848	0.000
C63.9 Male genital organ, unspecified	0.151	0.848	0.000
C63.8 Overlapping lesion of male genital organs	0.151	0.848	0.000
C63.7 Other specified male genital organs	0.151	0.848	0.000
C63.2 Scrotum	0.151	0.848	0.000
C63.1 Spermatic cord	0.151	0.848	0.000
C63.0 Epididymis	0.151	0.848	0.000
C62 Malignant neoplasm of testis	0.150	0.850	0.000
C62.1 Descended testis	0.109	0.891	0.000
C62.0 Undescended testis	0.108	0.892	0.000
C62.9 Testis, unspecified	0.045	0.954	0.001
N20.1 Calculus of ureter	0.046	0.954	0.000
N20 Calculus of kidney and ureter	0.040	0.960	0.000
N20.2 Calculus of kidney with calculus of ureter	0.038	0.962	0.000
N20.0 Calculus of kidney	0.036	0.964	0.000
N20.9 Urinary calculus, unspecified	0.022	0.978	0.000
M48.06 Spinal stenosis (Lumbar region)	0.000	0.989	0.011
M48.0 Spinal stenosis	0.000	0.989	0.011
M48.09 Spinal stenosis (Site unspecified)	0.000	0.990	0.010
M48.00 Spinal stenosis (Multiple sites in spine)	0.000	0.991	0.009
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.991	0.009
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.991	0.009
N20-N23 Urolithiasis	0.009	0.991	0.000
K04.5 Chronic apical periodontitis	0.000	0.991	0.009
N60.3 Fibrosclerosis of breast	0.008	0.992	0.000
M48.04 Spinal stenosis (Thoracic region)	0.000	0.992	0.008
M48.05 Spinal stenosis (Thoracolumbar region)	0.000	0.992	0.008
M48.03 Spinal stenosis (Cervicothoracic region)	0.000	0.992	0.008
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.000	0.992	0.008
N60.8 Other benign mammary dysplasias	0.007	0.993	0.000
N60 Benign mammary dysplasia	0.007	0.993	0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.000	0.993	0.007
N21 Calculus of lower urinary tract	0.007	0.993	0.000
M48.02 Spinal stenosis (Cervical region)	0.000	0.993	0.007
K26 Duodenal ulcer	0.000	0.993	0.007
N60.2 Fibroadenosis of breast	0.007	0.993	0.000
K26.5 Chronic or unspecified with perforation	0.000	0.993	0.007
Z85.4 Personal history of malignant neoplasm of genital organs	0.007	0.993	0.000
N21.8 Other lower urinary tract calculus	0.006	0.993	0.000
N22 Calculus of urinary tract in diseases classified elsewhere	0.006	0.994	0.000
O82.1 Delivery by emergency Caesarean section	0.000	0.994	0.006
M11.26 Other chondrocalcinosis (Lower leg)	0.000	0.994	0.006
C73 Malignant neoplasm of thyroid gland	0.000	0.994	0.006
K26.4 Chronic or unspecified with haemorrhage	0.000	0.994	0.006
K26.0 Acute with haemorrhage	0.000	0.994	0.006
N60.0 Solitary cyst of breast	0.006	0.994	0.000
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.000	0.994	0.006
N21.1 Calculus in urethra	0.005	0.995	0.000
J34.3 Hypertrophy of nasal turbinates	0.005	0.995	0.000
O20.9 Haemorrhage in early pregnancy, unspecified	0.005	0.995	0.000
D07.5 Prostate	0.005	0.995	0.000
K26.1 Acute with perforation	0.000	0.995	0.005
N21.9 Calculus of lower urinary tract, unspecified	0.005	0.995	0.000
N60.4 Mammary duct ectasia	0.005	0.995	0.000
K26.6 Chronic or unspecified with both haemorrhage and perforation	0.000	0.995	0.005
K26.2 Acute with both haemorrhage and perforation	0.000	0.995	0.005
Q61.0 Congenital single renal cyst	0.005	0.995	0.000
N22.8 Calculus of urinary tract in other diseases classified elsewhere	0.005	0.995	0.000
N22.0 Calculus of urinary tract in schistosomiasis [bilharziasis]	0.005	0.995	0.000
K26.3 Acute without haemorrhage or perforation	0.000	0.995	0.005
N60.1 Diffuse cystic mastopathy	0.005	0.995	0.000
S09.9 Unspecified injury of head	0.005	0.995	0.000
O82 Single delivery by Caesarean section	0.000	0.995	0.005
O82.9 Delivery by Caesarean section, unspecified	0.000	0.995	0.005
M24.16 Other articular cartilage disorders (Lower leg)	0.005	0.995	0.000
N60.9 Benign mammary dysplasia, unspecified	0.004	0.996	0.000
M48 Other spondylopathies	0.000	0.996	0.004
R82.9 Other and unspecified abnormal finding in urine	0.004	0.996	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.004	0.996	0.000
M24.13 Other articular cartilage disorders (Forearm)	0.004	0.996	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.004	0.996	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.004	0.996	0.000
X62.9 Unspecified place	0.004	0.996	0.000
S91.3 Open wound of other parts of foot	0.000	0.996	0.004
M24.1 Other articular cartilage disorders	0.004	0.996	0.000
R82 Other abnormal findings in urine	0.004	0.996	0.000
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.004	0.996	0.000
O82.8 Other single delivery by Caesarean section	0.000	0.996	0.003
O82.2 Delivery by Caesarean hysterectomy	0.000	0.996	0.003
M11.2 Other chondrocalcinosis	0.000	0.996	0.004
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
N21.0 Calculus in bladder	0.004	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.000	0.997	0.003
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
D07.2 Vagina	0.003	0.997	0.000
O82.0 Delivery by elective Caesarean section	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
M48.9 Spondylopathy, unspecified	0.000	0.997	0.003
M48.4 Fatigue fracture of vertebra	0.000	0.997	0.003
M48.3 Traumatic spondylopathy	0.000	0.997	0.003
M48.2 Kissing spine	0.000	0.997	0.003
M48.1 Ankylosing hyperostosis [Forestier]	0.000	0.997	0.003
T42.1 Iminostilbenes	0.003	0.997	0.000
M48.5 Collapsed vertebra, not elsewhere classified	0.000	0.997	0.003
O32.1 Maternal care for breech presentation	0.000	0.997	0.003
R82.7 Abnormal findings on microbiological examination of urine	0.003	0.997	0.000
D07.6 Other and unspecified male genital organs	0.003	0.997	0.000
D07.3 Other and unspecified female genital organs	0.003	0.997	0.000
D07.1 Vulva	0.003	0.997	0.000
D07.0 Endometrium	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
K26.7 Chronic without haemorrhage or perforation	0.000	0.997	0.003
I77.6 Arteritis, unspecified	0.000	0.997	0.003
G35 Multiple sclerosis	0.000	0.997	0.003
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
M48.8 Other specified spondylopathies	0.000	0.997	0.003
R07.0 Pain in throat	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
D07.4 Penis	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
D00-D09 In situ neoplasms	0.003	0.997	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.003	0.997	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.000	0.997	0.003
M24.19 Other articular cartilage disorders (Site unspecified)	0.003	0.997	0.000
M24.18 Other articular cartilage disorders (Other)	0.003	0.997	0.000
M24.14 Other articular cartilage disorders (Hand)	0.003	0.997	0.000
M24.12 Other articular cartilage disorders (Upper arm)	0.003	0.997	0.000
M24.10 Other articular cartilage disorders (Multiple sites)	0.003	0.997	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.003	0.997	0.000
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.003	0.997	0.000
R82.4 Acetonuria	0.003	0.997	0.000
R82.3 Haemoglobinuria	0.003	0.997	0.000
R82.2 Biliuria	0.003	0.997	0.000
R82.1 Myoglobinuria	0.003	0.997	0.000
R82.0 Chyluria	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
H25.9 Senile cataract, unspecified	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
M11.29 Other chondrocalcinosis (Site unspecified)	0.000	0.997	0.003
M11.28 Other chondrocalcinosis (Other)	0.000	0.997	0.003
M11.27 Other chondrocalcinosis (Ankle and foot)	0.000	0.997	0.003
M11.25 Other chondrocalcinosis (Pelvic region and thigh)	0.000	0.997	0.003
M11.24 Other chondrocalcinosis (Hand)	0.000	0.997	0.003
M11.23 Other chondrocalcinosis (Forearm)	0.000	0.997	0.003
M11.22 Other chondrocalcinosis (Upper arm)	0.000	0.997	0.003
M11.21 Other chondrocalcinosis (Shoulder region)	0.000	0.997	0.003
M11.20 Other chondrocalcinosis (Multiple sites)	0.000	0.997	0.003
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.000	0.997	0.003
E28.2 Polycystic ovarian syndrome	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
D00.0 Lip, oral cavity and pharynx	0.003	0.997	0.000
D04 Carcinoma in situ of skin	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.997	0.000
T42.3 Barbiturates	0.003	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
H35.8 Other specified retinal disorders	0.000	0.997	0.003
D02 Carcinoma in situ of middle ear and respiratory system	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.0 Penicillins	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
M48.19 Ankylosing hyperostosis [Forestier] (Site unspecified)	0.000	0.997	0.002
M48.18 Ankylosing hyperostosis [Forestier] (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M48.17 Ankylosing hyperostosis [Forestier] (Lumbosacral region)	0.000	0.997	0.002
M48.16 Ankylosing hyperostosis [Forestier] (Lumbar region)	0.000	0.997	0.002
M48.15 Ankylosing hyperostosis [Forestier] (Thoracolumbar region)	0.000	0.997	0.002
M48.14 Ankylosing hyperostosis [Forestier] (Thoracic region)	0.000	0.997	0.002
M48.13 Ankylosing hyperostosis [Forestier] (Cervicothoracic region)	0.000	0.997	0.002
M48.12 Ankylosing hyperostosis [Forestier] (Cervical region)	0.000	0.997	0.002
M48.11 Ankylosing hyperostosis [Forestier] (Occipito-atlanto-axial region)	0.000	0.997	0.002
M48.10 Ankylosing hyperostosis [Forestier] (Multiple sites in spine)	0.000	0.997	0.002
M48.29 Kissing spine (Site unspecified)	0.000	0.997	0.002
M48.28 Kissing spine (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M48.27 Kissing spine (Lumbosacral region)	0.000	0.997	0.002
M48.26 Kissing spine (Lumbar region)	0.000	0.997	0.002
M48.25 Kissing spine (Thoracolumbar region)	0.000	0.997	0.002
M48.24 Kissing spine (Thoracic region)	0.000	0.997	0.002
M48.23 Kissing spine (Cervicothoracic region)	0.000	0.997	0.002
M48.22 Kissing spine (Cervical region)	0.000	0.997	0.002
M48.21 Kissing spine (Occipito-atlanto-axial region)	0.000	0.997	0.002
M48.20 Kissing spine (Multiple sites in spine)	0.000	0.997	0.002
M48.39 Traumatic spondylopathy (Site unspecified)	0.000	0.997	0.002
M48.38 Traumatic spondylopathy (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M48.37 Traumatic spondylopathy (Lumbosacral region)	0.000	0.997	0.002
M48.36 Traumatic spondylopathy (Lumbar region)	0.000	0.997	0.002
M48.35 Traumatic spondylopathy (Thoracolumbar region)	0.000	0.997	0.002
M48.34 Traumatic spondylopathy (Thoracic region)	0.000	0.997	0.002
M48.33 Traumatic spondylopathy (Cervicothoracic region)	0.000	0.997	0.002
M48.32 Traumatic spondylopathy (Cervical region)	0.000	0.997	0.002
M48.31 Traumatic spondylopathy (Occipito-atlanto-axial region)	0.000	0.997	0.002
M48.30 Traumatic spondylopathy (Multiple sites in spine)	0.000	0.997	0.002
M48.49 Fatigue fracture of vertebra (Site unspecified)	0.000	0.997	0.002
M48.48 Fatigue fracture of vertebra (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M48.47 Fatigue fracture of vertebra (Lumbosacral region)	0.000	0.997	0.002
M48.46 Fatigue fracture of vertebra (Lumbar region)	0.000	0.997	0.002
M48.45 Fatigue fracture of vertebra (Thoracolumbar region)	0.000	0.997	0.002
M48.44 Fatigue fracture of vertebra (Thoracic region)	0.000	0.997	0.002
M48.43 Fatigue fracture of vertebra (Cervicothoracic region)	0.000	0.997	0.002
M48.42 Fatigue fracture of vertebra (Cervical region)	0.000	0.997	0.002
M48.41 Fatigue fracture of vertebra (Occipito-atlanto-axial region)	0.000	0.997	0.002
M48.40 Fatigue fracture of vertebra (Multiple sites in spine)	0.000	0.997	0.002
M48.99 Spondylopathy, unspecified (Site unspecified)	0.000	0.997	0.002
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M48.97 Spondylopathy, unspecified (Lumbosacral region)	0.000	0.997	0.002
M48.96 Spondylopathy, unspecified (Lumbar region)	0.000	0.997	0.002
M48.95 Spondylopathy, unspecified (Thoracolumbar region)	0.000	0.997	0.002
M48.94 Spondylopathy, unspecified (Thoracic region)	0.000	0.997	0.002
M48.93 Spondylopathy, unspecified (Cervicothoracic region)	0.000	0.997	0.002
M48.92 Spondylopathy, unspecified (Cervical region)	0.000	0.997	0.002
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)	0.000	0.997	0.002
M48.90 Spondylopathy, unspecified (Multiple sites in spine)	0.000	0.997	0.002
D04.7 Skin of lower limb, including hip	0.003	0.997	0.000
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.000	0.997	0.002
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.000	0.997	0.002
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.000	0.997	0.002
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.000	0.997	0.002
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.000	0.997	0.002
D02.0 Larynx	0.003	0.997	0.000
D04.5 Skin of trunk	0.003	0.997	0.000
O63.0 Prolonged first stage (of labour)	0.000	0.997	0.003
D09 Carcinoma in situ of other and unspecified sites	0.003	0.997	0.000
D00.1 Oesophagus	0.002	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
T44.0 Anticholinesterase agents	0.002	0.997	0.000
D09.1 Other and unspecified urinary organs	0.002	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
Z80.5 Family history of malignant neoplasm of urinary tract	0.003	0.997	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.002	0.997	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.002	0.997	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.997	0.003
T42.4 Benzodiazepines	0.002	0.998	0.000
M48.89 Other specified spondylopathies (Site unspecified)	0.000	0.998	0.002
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M48.87 Other specified spondylopathies (Lumbosacral region)	0.000	0.998	0.002
M48.85 Other specified spondylopathies (Thoracolumbar region)	0.000	0.998	0.002
M48.84 Other specified spondylopathies (Thoracic region)	0.000	0.998	0.002
M48.83 Other specified spondylopathies (Cervicothoracic region)	0.000	0.998	0.002
M48.82 Other specified spondylopathies (Cervical region)	0.000	0.998	0.002
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)	0.000	0.998	0.002
M48.80 Other specified spondylopathies (Multiple sites in spine)	0.000	0.998	0.002
H73.8 Other specified disorders of tympanic membrane	0.000	0.998	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
S02.00 Fracture of vault of skull (closed)	0.000	0.998	0.002
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.000	0.998	0.002
M24.11 Other articular cartilage disorders (Shoulder region)	0.002	0.998	0.000
M90.78 Fracture of bone in neoplastic disease (Other)	0.002	0.998	0.000
R94.4 Abnormal results of kidney function studies	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.002	0.998	0.000
C74 Malignant neoplasm of adrenal gland	0.000	0.998	0.002
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.002	0.998	0.000
D00.2 Stomach	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.002	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.998	0.002
D04.6 Skin of upper limb, including shoulder	0.002	0.998	0.000
R22.1 Localised swelling, mass and lump, neck	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
D04.2 Skin of ear and external auricular canal	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
S06.00 Concussion (without open intracranial wound)	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Z01.4 Gynaecological examination (general)(routine)	0.002	0.998	0.000
C67.2 Lateral wall of bladder	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.000	0.998	0.002
D04.9 Skin, unspecified	0.002	0.998	0.000
D04.8 Skin of other sites	0.002	0.998	0.000
D04.0 Skin of lip	0.002	0.998	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.000	0.998	0.002
G12.2 Motor neuron disease	0.002	0.998	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.998	0.002
D02.4 Respiratory system, unspecified	0.002	0.998	0.000
D02.3 Other parts of respiratory system	0.002	0.998	0.000
D02.2 Bronchus and lung	0.002	0.998	0.000
D02.1 Trachea	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
M48.86 Other specified spondylopathies (Lumbar region)	0.000	0.998	0.002
M90.72 Fracture of bone in neoplastic disease (Upper arm)	0.002	0.998	0.000
M90.7 Fracture of bone in neoplastic disease	0.002	0.998	0.000
Z90.6 Acquired absence of other parts of urinary tract	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
M24.17 Other articular cartilage disorders (Ankle and foot)	0.002	0.998	0.000
D01.3 Anus and anal canal	0.002	0.998	0.000
D04.1 Skin of eyelid, including canthus	0.002	0.998	0.000
D04.4 Skin of scalp and neck	0.002	0.998	0.000
D09.9 Carcinoma in situ, unspecified	0.002	0.998	0.000
D09.7 Carcinoma in situ of other specified sites	0.002	0.998	0.000
D09.3 Thyroid and other endocrine glands	0.002	0.998	0.000
D09.2 Eye	0.002	0.998	0.000
Z80.9 Family history of malignant neoplasm, unspecified	0.002	0.998	0.000
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)	0.002	0.998	0.000
C67.4 Posterior wall of bladder	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
S62.50 Fracture of thumb (closed)	0.000	0.998	0.002
D01.9 Digestive organ, unspecified	0.002	0.998	0.000
D01.7 Other specified digestive organs	0.002	0.998	0.000
D01.5 Liver, gallbladder and bile ducts	0.002	0.998	0.000
D01.4 Other and unspecified parts of intestine	0.002	0.998	0.000
D01.2 Rectum	0.002	0.998	0.000
D01.1 Rectosigmoid junction	0.002	0.998	0.000
D01.0 Colon	0.002	0.998	0.000
T40.2 Other opioids	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Z83.7 Family history of diseases of the digestive system	0.000	0.998	0.002
M05.9 Seropositive rheumatoid arthritis, unspecified	0.002	0.998	0.000
M07.3 Other psoriatic arthropathies	0.000	0.998	0.002
C74.9 Adrenal gland, unspecified	0.000	0.998	0.002
F00.9 Dementia in Alzheimer's disease, unspecified	0.002	0.998	0.000
G37 Other demyelinating diseases of central nervous system	0.000	0.998	0.002
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.002	0.998	0.000
C74.1 Medulla of adrenal gland	0.000	0.998	0.002
C74.0 Cortex of adrenal gland	0.000	0.998	0.002
X62.0 Home	0.002	0.998	0.000
X62.8 Other specified place	0.002	0.998	0.000
X62.7 Farm	0.002	0.998	0.000
X62.6 Industrial and construction area	0.002	0.998	0.000
X62.5 Trade and service area	0.002	0.998	0.000
X62.4 Street and highway	0.002	0.998	0.000
X62.3 Sports and athletics area	0.002	0.998	0.000
X62.2 School, other institution and public administrative area	0.002	0.998	0.000
X62.1 Residential institution	0.002	0.998	0.000
M79.28 Neuralgia and neuritis, unspecified (Other)	0.002	0.998	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.002	0.998	0.000
D04.3 Skin of other and unspecified parts of face	0.002	0.998	0.000
E13.9 Without complications	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
Z97.5 Presence of (intra-uterine) contraceptive device	0.000	0.998	0.002
G35-G37 Demyelinating diseases of the central nervous system	0.000	0.998	0.002
C75.8 Pluriglandular involvement, unspecified	0.000	0.998	0.001
C75.5 Aortic body and other paraganglia	0.000	0.998	0.001
C75.4 Carotid body	0.000	0.998	0.001
C75.3 Pineal gland	0.000	0.998	0.001
C75.2 Craniopharyngeal duct	0.000	0.998	0.001
C75.1 Pituitary gland	0.000	0.998	0.001
C75.0 Parathyroid gland	0.000	0.998	0.001
M24.02 Loose body in joint (Upper arm)	0.002	0.998	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.998	0.002
T50.8 Diagnostic agents	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
M90.79 Fracture of bone in neoplastic disease (Site unspecified)	0.002	0.998	0.000
M90.77 Fracture of bone in neoplastic disease (Ankle and foot)	0.002	0.998	0.000
M90.76 Fracture of bone in neoplastic disease (Lower leg)	0.002	0.998	0.000
M90.74 Fracture of bone in neoplastic disease (Hand)	0.002	0.998	0.000
M90.73 Fracture of bone in neoplastic disease (Forearm)	0.002	0.998	0.000
M90.71 Fracture of bone in neoplastic disease (Shoulder region)	0.002	0.998	0.000
M90.70 Fracture of bone in neoplastic disease (Multiple sites)	0.002	0.998	0.000
N95.8 Other specified menopausal and perimenopausal disorders	0.000	0.998	0.002
L92 Granulomatous disorders of skin and subcutaneous tissue	0.000	0.998	0.002
M90.10 Periostitis in other infectious diseases classified elsewhere (Multiple sites)	0.002	0.998	0.000
D09.0 Bladder	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
C67.3 Anterior wall of bladder	0.000	0.998	0.002
H53.1 Subjective visual disturbances	0.000	0.998	0.002
N18.4 Chronic kidney disease, stage 4	0.000	0.998	0.002
S68.1 Traumatic amputation of other single finger (complete)(partial)	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
D03 Melanoma in situ	0.002	0.998	0.000
M90.1 Periostitis in other infectious diseases classified elsewhere	0.002	0.998	0.000
C67 Malignant neoplasm of bladder	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
M90 Osteopathies in diseases classified elsewhere	0.002	0.998	0.000
O20 Haemorrhage in early pregnancy	0.002	0.998	0.000
C71.0 Cerebrum, except lobes and ventricles	0.002	0.998	0.000
C75.9 Endocrine gland, unspecified	0.001	0.998	0.001
S09 Other and unspecified injuries of head	0.002	0.998	0.000
C71.2 Temporal lobe	0.002	0.998	0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.000	0.998	0.002
S68.0 Traumatic amputation of thumb (complete)(partial)	0.000	0.998	0.002
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.998	0.002
C08.0 Submandibular gland	0.002	0.998	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.998	0.002
D06 Carcinoma in situ of cervix uteri	0.002	0.998	0.000
D05 Carcinoma in situ of breast	0.002	0.998	0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.002	0.998	0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.002	0.998	0.000
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.002	0.998	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.002	0.998	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.002	0.998	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.002	0.998	0.000
M07.38 Other psoriatic arthropathies (Other)	0.000	0.998	0.002
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.998	0.002
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.998	0.002
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.998	0.002
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.998	0.002
D03.2 Melanoma in situ of ear and external auricular canal	0.002	0.998	0.000
M79.2 Neuralgia and neuritis, unspecified	0.002	0.998	0.000
S56.1 Injury of flexor muscle and tendon of other finger(s) at forearm level	0.002	0.998	0.000
D03.5 Melanoma in situ of trunk	0.002	0.998	0.000
G37.5 Concentric sclerosis [Balo]	0.000	0.998	0.002
G37.4 Subacute necrotising myelitis	0.000	0.998	0.002
G37.2 Central pontine myelinolysis	0.000	0.998	0.002
G37.1 Central demyelination of corpus callosum	0.000	0.998	0.002
G37.0 Diffuse sclerosis	0.000	0.998	0.002
C13 Malignant neoplasm of hypopharynx	0.002	0.998	0.000
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.001	0.998	0.000
C13.0 Postcricoid region	0.002	0.998	0.000
C44.2 Skin of ear and external auricular canal	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
K86.2 Cyst of pancreas	0.002	0.998	0.000
N75.1 Abscess of Bartholin's gland	0.002	0.998	0.000
S09.0 Injury of blood vessels of head, not elsewhere classified	0.002	0.998	0.000
S62.5 Fracture of thumb	0.000	0.998	0.002
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.002	0.998	0.000
C00.0 External upper lip	0.002	0.998	0.000
M88.9 Paget's disease of bone, unspecified	0.002	0.998	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.002	0.998	0.000
Q61 Cystic kidney disease	0.002	0.998	0.000
D03.4 Melanoma in situ of scalp and neck	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations